Acadia Healthcare Company, Inc. financials

ACHC CIK 0001520697

Source: EDGAR filings · Built 2026-06-02T02:13:50Z

Custom taxonomy namespace: ffd

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow -439.91M -560.69M 38.21M 84.42M 98.53M 433.29M
Working Capital 288.94M -427.00K -289.78M 117.80M 90.17M 1.22B
Net Debt 2.52B 2.02B 1.41B 1.44B 1.52B 2.89B
Net Margin -33.29% 8.10% -0.74% 10.46% 8.24% -32.16%
Return on Equity (ROE) -56.58% 8.32% -0.78% 9.71% 7.57% -35.39%
Return on Assets (ROA) -19.95% 4.29% -0.40% 5.48% 4.00% -10.34%
Current Ratio 1.55× 1.00× 0.67× 1.30× 1.22× 1.93×
Debt-to-Equity 1.36× 0.68× 0.54× 0.55× 0.66× 1.72×
Effective Tax Rate -2.44% 22.64% 38.25% 25.15% 24.50% 22.09%
Cash Conversion Ratio -0.12× 0.51× -21.34× 1.39× 1.96× -0.98×
Accruals Ratio -0.22× 0.02× -0.09× -0.02× -0.04× -0.20×
SBC % of Revenue 0.96% 1.18% 1.10% 1.14% 1.62% 1.08%
CapEx Coverage 0.23× 0.19× 1.09× 1.29× 1.36× 2.92×
Free Cash Flow Per Share $-4.85 $-6.09 $0.42 $0.92 $1.09 $4.89

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 14.26× 27.62× 28.90×
P/FCF 185.10× 89.27× 55.93× 10.28×
FCF Yield 0.54% 1.12% 1.79% 9.73%
P/S 0.39× 1.15× 2.42× 2.84× 2.33× 2.12×
P/B 0.66× 1.18× 2.55× 2.63× 2.15× 2.33×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 3.31B 3.15B 2.93B 2.61B 2.31B 2.09B
Income Tax Expense (Benefit) 25.98M 77.39M -9.70M 94.11M 67.56M 40.61M
Net Income (Loss) Attributable to Parent -1.10B 255.61M -21.67M 273.14M 190.63M -672.13M
Earnings Per Share, Basic $-12.16 $2.79 $-0.24 $3.05 $2.15 $-7.65
Weighted Average Number of Shares Outstanding, Basic 90.70M 91.62M 90.95M 89.68M 88.77M 87.88M
Earnings Per Share, Diluted $-12.16 $2.78 $-0.24 $2.98 $2.10 $-7.59
Weighted Average Number of Shares Outstanding, Diluted 90.70M 92.06M 90.95M 91.56M 90.79M 88.59M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 133.24M 76.31M 100.07M 97.65M 133.81M 378.70M
Assets, Current 814.14M 577.49M 596.00M 506.13M 495.03M 2.52B
Assets 5.53B 5.96B 5.36B 4.99B 4.77B 6.50B
Long-term Debt 2.50B 1.96B 1.37B 1.39B 1.50B 3.12B
Liabilities, Current 525.19M 577.92M 885.78M 388.33M 404.86M 1.31B
Long-term Debt, Excluding Current Maturities 2.47B 1.88B 1.34B 1.36B 1.48B 2.97B
Liabilities 3.39B 2.77B 2.47B 2.09B 2.19B 4.54B
Stockholders' Equity Attributable to Parent 1.95B 3.07B 2.78B 2.81B 2.52B 1.90B
Common Stock, Shares, Outstanding 90.45M 91.78M 91.26M 89.91M 89.03M 88.02M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 131.90M 129.69M 462.34M 380.57M 374.48M 658.81M
Payments to Acquire Property, Plant, and Equipment 571.81M 690.38M 424.13M 296.15M 244.81M 224.96M
Net Cash Provided by (Used in) Investing Activities -556.21M -736.48M -397.22M -305.83M 1.01B -281.84M
Payments for Repurchase of Common Stock 50.03M
Net Cash Provided by (Used in) Financing Activities 481.25M 583.02M -62.70M -110.90M -1.64B -51.50M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (ACHC CIK 0001520697), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

FSTR

L.B. Foster Company

PHM

PULTEGROUP, INC.

AIZ

Assurant, Inc.